Charles Schwab’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.6M | Sell |
|
|||||
|
2025
Q2 | $17.1M | Buy |
|
|||||
|
2025
Q1 | $21.1M | Sell |
|
|||||
|
2024
Q4 | $31.8M | Buy |
|
|||||
|
2024
Q3 | $27.6M | Buy |
|
|||||
|
2024
Q2 | $36.3M | Buy |
|
|||||
|
2024
Q1 | $54.3M | Buy |
|
|||||
|
2023
Q4 | $54.1M | Buy |
|
|||||
|
2023
Q3 | $33.5M | Buy |
|
|||||
|
2023
Q2 | $75.5M | Sell |
|
|||||
|
2023
Q1 | $64.9M | Buy |
|
|||||
|
2022
Q4 | $50.8M | Buy |
|
|||||
|
2022
Q3 | $64.8M | Buy |
|
|||||
|
2022
Q2 | $30.7M | Buy |
|
|||||
|
2022
Q1 | $33.3M | Buy |
|
|||||
|
2021
Q4 | $28M | Buy |
|
|||||
|
2021
Q3 | $17.1M | Buy |
|
|||||
|
2021
Q2 | $26.5M | Buy |
|
|||||
|
2021
Q1 | $17.3M | Buy |
|
|||||
|
2020
Q4 | $21.5M | Buy |
|
|||||
|
2020
Q3 | $11.1M | Buy |
|
|||||
|
2020
Q2 | $11.8M | Buy |
|
|||||
|
2020
Q1 | $8.87M | Buy |
|
|||||
|
2019
Q4 | $8.25M | Buy |
|
|||||
|
2019
Q3 | $6.29M | Buy |
|
|||||
|
2019
Q2 | $6.22M | Buy |
|
|||||
|
2019
Q1 | $4.12M | Buy |
|
|||||
|
2018
Q4 | $2.54M | Sell |
|
|||||
|
2018
Q3 | $3.42M | Buy |
|
|||||
|
2018
Q2 | $3.79M | Buy |
|
|||||
|
2018
Q1 | $944K | Buy |
|
|||||
|
2017
Q4 | $863K | Buy |
|